ResearcherKyushu UniversityActive in the last 2 years
Akihisa Ohno
Matched on ORCID iD 0000-0003-1372-166X; OpenAlex author ID A5025211547. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 6
- Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-025-03633-4↗
- Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. Co-author DOI 10.1007/s00535-024-02103-0↗
- Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship with the prognosis Co-author DOI 10.21203/rs.3.rs-4088010/v1↗
- Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study. Co-author DOI 10.1007/s12672-021-00462-1↗
- Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer. Co-author DOI 10.1186/s12885-022-10207-0↗
- Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrine neoplasm type 1. Co-author DOI 10.1007/s12328-020-01234-0↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nao Fujimori · 6 shared papers, 2021–2026 · strength 1.02
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Yoshihiro Ogawa · 6 shared papers, 2021–2026 · strength 1.02
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Katsuhito Teramatsu · 5 shared papers, 2022–2026 · strength 0.90
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Masatoshi Murakami · 5 shared papers, 2022–2026 · strength 0.90
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Kazuhide Matsumoto · 5 shared papers, 2022–2026 · strength 0.90
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship… DOI 10.21203/rs.3.rs-4088010/v1↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Kohei Nakata · 3 shared papers, 2022–2024 · strength 0.44
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Paper Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer. DOI 10.1186/s12885-022-10207-0↗
- Paper Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic canc… DOI 10.1007/s12672-021-00462-1↗
- Yoshinao Oda · 2 shared papers, 2024–2026 · strength 0.41
- Paper Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. DOI 10.1038/s41388-025-03633-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Masafumi Nakamura · 3 shared papers, 2021–2022 · strength 0.39
- Paper Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer. DOI 10.1186/s12885-022-10207-0↗
- Paper Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic canc… DOI 10.1007/s12672-021-00462-1↗
- Paper Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrin… DOI 10.1007/s12328-020-01234-0↗
- Takehiro Takaoka · 1 shared paper, 2024 · strength 0.22
- Masafumi Nakamura · 1 shared paper, 2024 · strength 0.17
- Koki Oyama · 1 shared paper, 2022 · strength 0.14
- Kousei Ishigami · 1 shared paper, 2022 · strength 0.13
- Toshiya Abe · 1 shared paper, 2022 · strength 0.13
- Noboru Ideno · 1 shared paper, 2022 · strength 0.13
- Naoki Ikenaga · 1 shared paper, 2022 · strength 0.13
- Tetsuhide Ito · 1 shared paper, 2021 · strength 0.12
- Hisato Igarashi · 1 shared paper, 2021 · strength 0.12
- Ryota Matsuda · 1 shared paper, 2021 · strength 0.12
- Yoshinao Oda · 1 shared paper, 2021 · strength 0.12
- Masami Miki · 1 shared paper, 2021 · strength 0.12
- Takao Ohtsuka · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.